Targeting miR-375 in gastric cancer

Targeting miR-375 in gastric cancer
复制标题

靶向 miR-375 在胃癌中的作用

DOI:
10.1517/14728222.2011.581232
复制
发表时间:
2011-07
影响因子:
5.8
通讯作者:
Zhou T
Zhou T
中科院分区:
医学2区
文献类型:
--
作者:
Xu Y;Deng Y;Yan X;Zhou T

文献摘要

参考文献

相似文献

胃癌仍然是世界上主要的癌症负担,5年生存率很低。因此,有必要开发新的有效的治疗策略,以改善长期的临床结果。MicroRNA(miRNA)是一类小分子非编码RNA,是基因表达的重要调控因子,与胃癌的发生发展密切相关。涵盖的领域:本文综述了miRNAs在胃癌发生中的作用,重点介绍了miR-375在胃癌及其他组织中的表达和功能。本文还讨论了miR-375作为胃癌潜在治疗靶点的机遇和挑战。miR-375靶向的基因包括JAK 2和3′-磷酸肌醇依赖性蛋白激酶1(PDK 1),也是胃癌治疗的候选基因。专家意见:虽然根治性手术和合理的化疗仍是胃癌的主要治疗手段,但靶向miRNAs与其他常规治疗方法的联合应用可能会成为改善临床预后的一种有前景的治疗策略。
Introduction: Gastric cancer remains a major cancer burden in the world, with a poor 5-year survival rate. It is necessary to develop new effective therapeutic strategies to improve the long-term clinical outcome. MicroRNA (miRNA), a class of small non-coding RNA, has been identified as a key regulator of gene expression, and is implicated in the pathogenesis of gastric cancer. Areas covered: This review summarizes the role of miRNAs in gastric carcinogenesis, with an emphasis on the expression and function of miR-375 in gastric cancer and beyond. It also discusses the opportunities and challenges of miR-375 as a potential therapeutic target for gastric cancer. The genes targeted by miR-375, including JAK2 and 3′-phosphoinositide dependent protein kinase-1 (PDK1), are also candidates for gastric cancer therapy. Expert opinion: Although radical surgery and rational chemotherapy are still the main treatment for gastric cancer, targeting miRNAs, in combination with other conventional therapies, may serve as a promising therapy strategy to improve the clinical outcome.
MiR-218通过靶向Robo1受体抑制胃癌的侵袭和转移。
DOI: 10.1371/journal.pgen.1000879
发表时间: 2010-03-12
期刊: PLoS genetics
影响因子: 4.5
作者:
Tie J;Pan Y;Zhao L;Wu K;Liu J;Sun S;Guo X;Wang B;Gang Y;Zhang Y;Li Q;Qiao T;Zhao Q;Nie Y;Fan D
通讯作者: Fan D
DOI: 10.1038/onc.2009.140
发表时间: 2009-07-01
期刊: ONCOGENE
影响因子: 8
作者:
Saito, Y.;Suzuki, H.;Hibi, T.
通讯作者: Hibi, T.
DOI: 10.1093/nar/gkq1027
发表时间: 2011-01
影响因子: 14.9
作者:
Kozomara A;Griffiths-Jones S
通讯作者: Griffiths-Jones S
MicroRNA-221和microRNA-222通过靶向PTEN调节胃癌细胞增殖和放射抗性。
DOI: 10.1186/1471-2407-10-367
发表时间: 2010-07-12
期刊: BMC cancer
影响因子: 3.8
作者:
Chun-Zhi Z;Lei H;An-Ling Z;Yan-Chao F;Xiao Y;Guang-Xiu W;Zhi-Fan J;Pei-Yu P;Qing-Yu Z;Chun-Sheng K
通讯作者: Chun-Sheng K
DOI: 10.1158/1078-0432.ccr-08-3131
发表时间: 2009-04-15
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
Avissar M;Christensen BC;Kelsey KT;Marsit CJ
通讯作者: Marsit CJ